TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers at Albert Einstein College of Medicine report that restoring a cellular recycling process reduced senescent-cell buildup and lung fibrosis in aged mice. The study, published in Nature Aging, also found related evidence in human lung tissue, but it does not establish that the treatment is safe or effective in people.
Restoring a cellular recycling process reduced the buildup of senescent cells and signs of lung fibrosis in aged mice, researchers at Albert Einstein College of Medicine report in a study published October 5 in Nature Aging. The findings point to a possible way to help immune cells clear these cells, which can contribute to inflammation and age-related disease, but the experiments do not show that the approach works in people.
The study focused on chaperone-mediated autophagy (CMA), a process in which cells identify and break down selected proteins. The researchers found that CMA activity declined with age in both senescent cells and macrophages, immune cells that can engulf and clear senescent cells. In experiments, senescent cells with low CMA released substances that could encourage nearby healthy cells to become senescent and make macrophages less able to recognize and remove them.
In mice genetically altered so their macrophages lacked CMA, more senescent cells accumulated at wound sites and healing took longer than in control animals. The team also treated aged mice with the CMA-activating compound CA77.1. Five months of daily oral treatment was associated with fewer senescent cells in several organs and reduced signs of inflammation and fibrosis. In a separate laboratory experiment, CA77.1 restored the particle-engulfing ability of macrophages isolated from aged mice to levels comparable with those from young mice.
The researchers also examined human lung tissue in connection with idiopathic pulmonary fibrosis, a disease involving lung scarring and associated with aging. That analysis offers evidence that the mechanism may be relevant to people, but it does not demonstrate that CA77.1 treats the disease or that the same effects occur in patients.
A Possible Route to Clear Senescent Cells
Senescent cells stop dividing but remain alive. They can have useful, temporary roles: during wound healing, for example, they release signals that recruit cells involved in repair. Their persistence, however, can disrupt tissue and contribute to chronic inflammation. The study suggests that age-related decline in CMA may weaken both sides of the cleanup system: it can alter what senescent cells release and reduce macrophages’ ability to remove them.
That matters for research into aging-related illness because it points to a strategy that may support the body’s own clearance mechanisms. The findings also raise a practical issue for drug development: tests using cells made senescent in the laboratory from young animals may not capture how senescent cells or immune cells behave in older bodies. The mouse results are early evidence, not proof of a treatment for aging or lung disease.
As an affiliate, we earn on qualifying purchases.
How CMA and Cell Clearance Work
CMA is one of the cell’s protein-recycling pathways. Specialized chaperone molecules identify certain proteins and guide them for breakdown. Earlier work by study leader Ana Maria Cuervo and colleagues found that CMA activity declines with age and that reduced activity can allow damaged or unwanted proteins to build up in cells.
Researchers have also been investigating senolytic drugs, which are designed to eliminate senescent cells. The new study examines a different possibility: improving CMA in senescent cells and macrophages so that harmful cellular signals are reduced and immune clearance improves. Its experiments included genetically altered mice, aged mice treated with CA77.1, laboratory work on isolated cells, and analysis of human lung tissue.
senescent cell removal supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Human Benefits Remain Unproven
The available findings do not establish whether CA77.1 is safe or effective in people, what dose might be appropriate, or whether the effects seen in aged mice would translate to human disease. The human lung tissue analysis does not amount to a clinical trial. The supplied study report also does not provide results from treatment of people with idiopathic pulmonary fibrosis.
It remains unclear how broadly the results apply across age-related diseases, how long any benefit might last, and whether boosting CMA could have unwanted effects. Senescent cells can serve useful functions, including in wound repair, so the consequences of changing their activity or clearance need to be evaluated in further research.
As an affiliate, we earn on qualifying purchases.
Testing the Approach in People
The researchers identify the relevance of their findings to age-associated disease, including idiopathic pulmonary fibrosis, as an area for further investigation. The next steps would need to establish how CA77.1 acts, assess its safety and dosing, and test whether the mouse results hold in human studies. The supplied report does not specify a timeline for clinical trials or describe a planned trial.
As an affiliate, we earn on qualifying purchases.
Key Questions
What are senescent, or “zombie,” cells?
They are living cells that have stopped dividing. They can help with processes such as wound repair, but if they persist they may disrupt tissue function and contribute to inflammation.
What did the study find in aged mice?
After five months of daily oral CA77.1, aged mice had fewer senescent cells in several organs and reduced signs of inflammation and fibrosis, according to the researchers.
Does CA77.1 treat lung fibrosis in people?
The study does not show that. It reports mouse experiments and an analysis of human lung tissue, not a clinical trial demonstrating safety or benefit in patients.
Why might older cells be harder to clear?
The researchers found that CMA activity declined with age in senescent cells and macrophages. They report that this was linked to altered secretions from senescent cells and weaker macrophage clearance in their experiments.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
